share_log

Chardan Capital Downgrades CervoMed to Neutral

Benzinga ·  Dec 11, 2024 04:18

Chardan Capital analyst Daniil Gataulin downgrades CervoMed (NASDAQ:CRVO) from Buy to Neutral.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment